As of Friday close, Chimerix Inc.’s (NASDAQ:CMRX) stock was down -$0.02, moving down -1.74 percent to $0.94. The average number of shares traded per day over the past five days has been 866,200 shares. 3 times new highs have been achieved over the past 5 days, with a -$0.0346 fall in that time frame. In the last twenty days, the average volume was 841,395, while in the previous 50 days, it was 1,061,152.
Since last month, CMRX stock retreated -20.76%. Shares of the company fell to $0.9200 on 08/18/23, the lowest level in the past month. A 52-week high of $2.68 was reached on 01/13/23 after having rallying from a 52-week low of $0.94. Since the beginning of this year, CMRX’s stock price has dropped by -49.31% or -$0.9171, and marked a new high 6 times. However, the stock has declined by -64.82% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
CMRX stock investors should be aware that Chimerix Inc. (CMRX) stock had its last reported insider trading activity 93 days ago on May 18. Andriole Michael T., the Chief Business Officer and CFO of the company, purchased of 51,700 shares for $1.14 on May 18. It resulted in a $59,150 investment by the insider. Sherman Michael A. added 87,000 shares at an average price of $1.12 on May 12. The insider now owns 87,000 shares following the transaction. On May 10, Director DEMSKI MARTHA J bought 18,000 shares at $1.11 apiece. The transaction was valued at $19,980.
Valuation Metrics
Right now, Chimerix Inc. (CMRX) has a P/E ratio of about 0.46. The stock’s beta is 1.15. Besides these, the trailing price-to-sales (P/S) ratio of 2.56, the price-to-book (PB) ratio of 0.37.
Financial Health
On the profitability front, the trailing twelve-month gross margin is 99.00% percent. Based on annual data, CMRX earned $33.38 million in gross profit and brought in $33.82 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -23.50%. Return on equity (ROE) for the past 12 months was 72.50%.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. CMRX’s revenue fell -1366.67% to $0.28 million during the quarter, while net income inched up to $30000.0. While analysts expected Chimerix Inc. to report -$0.24 quarterly earnings, the actual figure was -$0.21 per share, beating the consensus estimate by 12.50%. During the quarter, the company generated -$23.16 million in EBITDA. The liabilities of Chimerix Inc. were 16.97 million at the end of its most recent quarter ended June 29, and its total debt was $2.11 million. The value of shareholders’ equity is $88.58 million.
Technical Picture
This quick technical analysis looks at Chimerix Inc.’s (CMRX) price momentum. With a historical volatility rate of 25.47%, the RSI 9-day stood at 18.45% on 18 August.
With respect to its five-day moving average, the current Chimerix Inc. price is down by -3.54% percent or -$0.0346. At present, CMRX shares trade -21.43% below its 20-day simple moving average and -22.07% percent below its 100-day simple moving average. However, the stock is currently trading approximately -34.97% below its SMA50 and -46.73% below its SMA200.
Stochastic coefficient K was 6.45% and Stochastic coefficient D was 7.07%, while ATR was 0.0506. Given the Stochastic reading of 8.18% for the 14-day period, the RSI (14) reading has been calculated as 24.10%. As of today, the MACD Oscillator reading stands at -0.0344, while the 14-day reading stands at -0.0878.
Analyst Ratings
Robert W. Baird launched its rating on Chimerix Inc. (NASDAQ: CMRX) to an Outperform in a note to investors on May 23, 2023. Chimerix Inc. (CMRX) has been rated Buy by analysts. According to 0 brokerage firms, CMRX is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 2 analysts rate Chimerix Inc. stock as buy, with 5 recommending it as overweight.
With a median target price of $7.00, the current consensus forecast for the stock is $5.00 – $11.00. Based on these forecasts, analysts predict Chimerix Inc. (CMRX) will achieve an average price target of $7.00.
